TCDD causes suppression of growth and differentiation of MCF10A, human mammary epithelial cells by interfering with their insulin receptor signaling through c-Src kinase and ERK activation

Journal of Biochemical and Molecular Toxicology

Volumn 18, Issue 6, 2005, Pages 322-331

  Park, Sujin ^a   Mazina, Olga ^a   Kitagawa, Akira ^a   Wong, Patrick ^a   Matsumura, Fumio ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dioxin; Insulin Signaling; MCF10A Breast Epithelial Cells; Src tyrosine kinase; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ANTISENSE OLIGONUCLEOTIDE; CHOLERA TOXIN; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE;

ARTICLE; BREAST EPITHELIUM; CELL DIFFERENTIATION; CELL GROWTH; GENE REPRESSION; HUMAN; HUMAN CELL; SIGNAL TRANSDUCTION;

EID: 12844265289     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbt.20040     Document Type: Article

References (30)

1. Fenton SE, Hamm JT, Birnbaum LS, Youngblood GL. Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci 2002;67:63-74.
2. Brown NM, Manzolillo PA, Zhang JX, Wang J, Lamartiniere CA. Prenatal TCDD and predisposition to mammary cancer in the rat. Carcinogenesis 1998;19:1623-1629.
3. Lamartiniere, CA. Timing of exposure and mammary cancer risk. J Mammary Gland Biol Neoplasia 2002;7:67-76.
4. McGrath CM, Soule HD. Renewal inhibition of human mammary cell growth in vitro: Cortisol and the recruitment of cells to terminal differentiation. J Cell Physiol 1983;116:385-396.
5. Russo J, Mills MJ, Moussalli MJ, Russo IH. Influence of human breast development on the growth properties of primary cultures. In Vitro Cell Dev Biol 1989;25:643-649.
6. Madhukar BV, Brewster DW, Matsumura F. Effects of in vivo-administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on receptor binding of epidermal growth factor in the hepatic plasma membrane of rat, guinea pig, mouse, and hamster. Proc Natl Acad Sci USA 1985;81:7407-7411.
7. Ebner K, Brewster DW, Matsumura F. Effects of 2,3,7,8-tetrachlorodibenzo- p-dioxin on serum insulin and glucose levels in the rabbit. J Environ Sci Health 1998;1323:427-438.
8. Matsumura F, Madhukar BV, Bombick DW, Brewster DW. Toxicological significance of pleiotropic changes of plasma membrane functions particularly that of EGF receptor caused by 2,3,7,8-TCDD. In: Banbury Report: Biological Mechanisms of Dioxin Action. Plainview, NY: Cold Spring Harbor Laboratory; 1984. Vol. 18, pp 267-287.
9. Masui H, Hyman J, Mendelsohn J. Epidermal growth factor (EGF) requirement for insulin-stimulated proliferation of MCF10A human mammary epithelial cells. Proc. 87th Annual Meeting American Association for Cancer Research, Washington, DC, 1996, Vol.37, p. 217.
10. Tannheimer SL, Ethier SP, Caldwell KK, Burchiel SW. Benzo(a)pyrene- and TCDD-induced alterations in tyrosine phosphorylation and insulin-like growth factor signaling pathways in the MCF-10A human mammary epithelial cell line. Carcinogenesis 1998;19:1291-1297.
11. Matsumura F. Commentary: How important is the protein phosphorylation pathway in the toxic action of dioxin-type chemicals. Biochem Pharmacol 1994;48:215-224.
12. Reiners JJ, Lee JY, Clift RE, Dudley DT, Myrand SP. PD98059 is an equipotent antagonist of the ary hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase. Mol Pharmacol 1998;53:438-445.
13. Yavelow J, Tuccillo A, Kadner SS, Katz J, Finlay TH. Alpha 1-antitrypsin blocks the release of transforming growth factor-alpha from MCF-7 human breast cancer cells. J Clin Endocrinol Metab 1997;82:745-752.
14. Kohle C, Gschaidmeier H, Lauth D, Topell S, Zitler H, Bock KW. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-mediated membrane translocation of c-Src protein kinase in liver WB-F344 cells. Arch Toxicol 1999;73:152-158.
15. Bombick DW, Matsumura F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes elevation of the levels of the protein tyrosine kinase pp60 c-src. J Biochem Toxicol 1987;2:141-154.
16. Shi S, Garcia JG, Roy S, Parinandi NL, Natarajan V. Involvement of c-Src in diperoxovanadate-induced endothelial cell barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2002;279(3):L441-L451.
17. Elliott J, Jones MD, Griffin BE, Krauzewicz N. Regulation of cytoskeletal association by a basic amino acid motif in polyoma virus middle T antigen. Oncogene 1998;17(14):1797-1806.
18. Cirillo D, Comoglio PM, Naldini L, Marchisio PC. Visualization of phosphotyrosine containing molecules within the detergent insoluble cell matrix of v-src transformed fibroblasts. Cell Biol Int Rep 1984;8(11):959-969.
19. Eithier SP, Summerfelt RM, Cundiff KC, Asch BB. The influence of growth factors on the proliferative potential of normal and primary breast cancer-derived human breast epithelial cells. Breast Cancer Res Treat 1991;17(3):221-230.
20. Eithier SP, Mahacek ML, Gullick WJ, Frank TS, Weber BL. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res 1993;53(3):627-635.
21. Yang J, Balakrishnan A, Hamamoto S, Elias JJ, Rosenau W, Beattie CW, Das Gupta TK, Wellings SR, Nandi S. Human breast epithelial cells in serum-free collagen gel primary culture: Growth, morphological, and immunocytochemical analysis. J Cell Physiol 1987;133(2):228-234, 254-255.
22. Perusinghe NP, Monaghan P, O'Hare MJ, Ashley S, Gusterson BA. Effects of growth factors on proliferation on basal and luminal cells in human breast epithelial explants in serum-free culture. In Vitro Cell Dev Biol 1992;28A(2):90-96.
23. Mork C, van Deurs B, Petersen OW. Regulation of vimentin expression in cultured human mammary epithelial cells. Differentiation 1990;43(2):146-156.
24. Salle V, Souttou B, Magnien V, Israel L, Crepin M. Growth factors of cultured epithelial cells of breast diseases and breast carcinoma. Bull Cancer 1992;79(2):133-140.
25. Yan Z, Yang DC, Jett M. Cholera toxin induces tumor necrosis factor alpha production in human monocytes. Mol Cell Biol Res Commun 1999;2:124-130.
26. Han XB, Conn PM. The role of protein kinases A and C pathways in the regulation of mitogen-activated protein kinase activation in response to gonadotropin-releasing hormone receptor activation. Endocrinology 1991;140:2241-2251.
27. Calalb MB, Polte TR, Hanks SK. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: A role for Src family kinases. Mol Cell Biol 1995;15:954-963.
28. Kaburagi Y, Satho S, Tamemoto H, Yamamoto-Honda R, Tobe K, Veki K, Yamauchi T, Kono-Sugita E, Sekihara H, Aizawa S. Role of insulin receptor substrate-1 and pp60 in the regulation of insulin-induced glucose transport and GLUT4 translocation in primary adipocytes. J Biol Chem 1997;272:5839-5844.
29. Lebrun P, Mothe-Satney I, Delahaye L, van Obberghen E, Baron B. Insulin receptor substrate-1 as a signaling molecule for focal adhesion kinase pp125(FAK) and pp60(src). J Biol Chem 1998;273:32244-33253.
30. Ramachandran C, Kennedy BP. Protein tyrosine phosphatase 1B: A novel target for type 2 diabetes and obesity. Curr Top Med Chem 2003;3(7):749-757.